Effect of diabetes mellitus on endotoxin-induced lung injury

Archives of Surgery

Volumn 134, Issue 12, 1999, Pages 1354-1359

  Wright, Joseph Keith ^a   Nwariaku, Fiemu N ^a   Clark, Jason ^a   Falck, J Cameron ^a   Rogers, Thomas ^a   Turnage, Richard H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; ENDOTOXIN; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DIABETES MELLITUS; LEUKOCYTE ACTIVATION; LUNG EDEMA; LUNG INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RAT;

EID: 0032715181     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.134.12.1354     Document Type: Article

References (37)

1. Peterson RG, Shaw WN, Neel M-A, Little LA, Eichberg J. Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus. Indiana Lab Animal Res News. 1990;32:16-19.
2. Delclaux C, Rezaiguia-Delclaux S, Delacourt C, Brun-Buisson C, Lafuma C, Hart A. Alveolar neutrophils in endotoxin-induced and bacteria-induced acute lung injury in rats. Am J Physiol. 1997;273:L104-L112.
3. van Helden HPM, Kuijpers WC, Steenvoorden D, Go C, Bruijnzeel PLB. Intratracheal aerosolization of endotoxin (LPS) in the rat. Exp Lung Res. 1997;23:297-316.
4. Venaille T, Snella M-C, Holt PG, Rylander R. Cell recruitment into lung wall and airways of conventional and pathogen-free guinea pigs after inhalation of endotoxin. Am Rev Respir Dis. 1989;139:1356-1360.
5. Rabiniovici R, Bugelski PJ, Esser KM, et al. Tumor necrosis factor-α mediates endotoxin-induced lung injury in platelet activating factor-primed rats. J Pharmacol Exp Ther. 1993;267:1550-1557.
6. Li XY, Donaldson K, MacNee W. Lipopolysaccharide-induced alveolar epithelial permeability. Am J Respir Crit Care Med. 1998;157:1027-1033.
7. Tsuji C, Minhaz MU, Shioya S, Fukahori M, Tanigaki T, Nakazawa H. The importance of polymorphonuclear leukocytes in lipopolysaccharide-induced superoxide anion production and lung injury. Lung. 1998;176:1-13.
8. Lutz C, Carney D, Finck C, et al. Aerosolized surfactant improves pulmonary function in endotoxin-induced lung injury. Am J Respir Crit Care Med. 1998;158: 840-845.
9. Iglesias JL, LaNoue JL, Rogers TW, Inman L, Turnage RH. Physiologic basis of pulmonary edema during intestinal reperfusion. J Surg Res. 1998;80:156-163.
10. Patterson CE, Rhoades RA, Garcia JGN. Evans blue dye as a marker of albumin clearance in cultured endothelial monolayer and isolated lung. J Appl Physiol. 1992;72:865-873.
11. Ulich TR, Watson LR, Yin S, et al. The intratracheal administration of endotoxin and cytokines. Am J Pathol. 1991;138:1485-1496.
12. Rochemonteix-Galve B, Marchat-Amoruso B, Dayer J-M, Rylander R. Tumor necrosis factor and interleukin-1 activities in free lung cells after single and repeated inhalation of bacterial endotoxin. Infect Immun. 1991;59:3646-3650.
13. Xing Z, Jordana M, Kirpalani H, Driscoll KE, Schall TJ, Gauldie J. Cytokine expression by neutrophils and macrophages in vivo. Am J Respir Cell Mol Biol. 1994;10:148-153.
14. Valensi P, Cohen-Boulakia F, Attali JR, Behar A. Changes in capillary permeability in diabetic patients. Clin Hemorheol Microcirc. 1997;17:389-394.
15. Bent-Hansen L. Whole body capillary exchange of albumin: alterations in diabetic microangiopathy. Dan Med Bull. 1997;44:40-55.
16. Scher SM, Lawrence AM. Functional microangiopathy in alloxan diabetic rats. Acta Endocrinol (Copenh). 1971;66:357-367.
17. Colantuoni A, Berardi PG, Orefice G. Increased permeability of the microcirculation to high molecular weight dextran in experimental diabetes, shown by intravital microfluorimetry. J Nucl Med Allied Sci. 1979;23:49-54.
18. van den Born J, van Kraats AA, Hill S, Bakker MAH, Berden JHM. Vessel wall heparan sulfate and transcapillary passage of albumin in experimental diabetes in the rat. Nephrol Dial Transplant. 1997;12:27-31.
19. Chakir M, Plante GE. Endothelial dysfunction in diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids. 1996;54:45-51.
20. Tamsma JT, van den Born J, Bruijn JA, et al. Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulfate in the glomerular basement membrane. Diabetologia. 1994;37:313-320.
21. Vernier RL, Steffes MW, Sisson-Ross S, Mauer M. Heparan sulfate proteoglycan in the glomerular basement membrane in type I diabetes mellitus. Kidney Int. 1992;41:1070-1080.
22. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988; 38:1315-1320.
23. Schror K. Blood vessel wall interactions in diabetes. Diabetes. 1997;46(suppl 2): S115-S118.
24. Lash JM, Sherman WM, Hamlin RL. Capillary basement membrane thickness and capillary density in sedentary and trained obese Zucker rats. Diabetes. 1989; 38:854-860.
25. Vracko R, Thorning D, Huang TW. Basal lamina of alveolar epithelium and capillaries: quantitative changes with aging and in diabetes mellitus. Am Rev Respir Dis. 1979;120:973-983.
26. Delamaire M, Maugendre D, Moreno M, LeGoff M-C, Allannic H, Genetet B. Impaired leukocyte function in diabetic patients. Diabet Med. 1997;14:29-34.
27. Inoue S, Lan Y, Muran J, Masahiro T. Reduced hydrogen peroxide production in neutrophils from patients with diabetes. Diabetes Res Clin Pract. 1996;33:119-127.
28. Marhoffeer W, Stein M, Schleinkofer L, Federlin K. Evidence of ex vivo and in vitro impaired neutrophil oxidative burst and phagocytic capacity in type I diabetes mellitus. Diabet Res Clin Pract. 1993;19:183-188.
29. Alexiewicz JM, Kumar D, Smogorzewski M, Klin M, Massry SG. Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function. Ann Intern Med. 1995;123:919-924.
30. Braun RD, Fisher TC, Meiselman HJ, Hatchell DL. Decreased deformability of polymorphonuclear leukocytes in diabetic cats. Microcirculation. 1996;3:271-278.
31. Martin T, Pistorese PB, Chi EY, Goodman RB, Matthay MA. Effects of leukotriene B4 in the human lung. J Clin Invest. 1989;84:1609-1619.
32. Holman RT, Johnson SB, Gerrard JM, Mauer SM, Kupcho-Sandberg S, Brown DM. Arachidonic acid deficiency in streptozotocin-induced diabetes. Proc Natl Acad Sci U S A. 1983;80:2375-2379.
33. Nakagawa Y, Ishii E. Changes in arachidonic acid metabolism and the aggregation of polymorphonuclear leukocytes in rats with streptozotocin-induced diabetes. Biochim Biophys Acta. 1996;1315:145-151.
34. Watts IS, Zakrzewski JT, Bakhle YS. Altered prostaglandin synthesis in isolated lungs of rats with streptozotocin-induced diabetes. Thromb Res. 1982;28:333-342.
35. Fang C, Jiang Z, Tomlinson DR. Expression of constitutive cyclooxygenase (COX-1) in rats with streptozotocin-induced diabetes. Prostaglandins Leukot Essent Fatty Acids. 1997;56:157-163.
36. Malik AB, Perlman MB, Cooper JA, Noonan T, Bizios R. Pulmonary microvascular effects of arachidonic acid metabolites and their role in lung vascular injury. Fed Proc. 1985;44:36-42.
37. Brigham KL, Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis. 1986; 133:913-927.